Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers A > Headlines for Actavis plc > News item |
Convertibles weaker as stocks sell off; BPZ Resources files bankruptcy; Akorn tumbles
By Rebecca Melvin
New York, March 10 – Convertibles were weaker, with many names for sale, but not much trading on Tuesday as equities and oil prices sagged, market sources said.
“With the Dow down 1.5%, everything is generally for sale from the long-only, outright guys, and things are lower on swap,” a New York-based trader said.
BPZ Resources Inc.’s distressed convertibles slumped even lower after the Houston-based oil and natural gas exploration and production company filed for bankruptcy protection late Monday.
Energy XXI (Bermuda) Ltd.’s 3% convertibles were little changed, however, at 37.5 to 38.5 despite a slide in the underlying shares of the Houston-based energy exploration and production company, and the Energy XXI 5.625% perpetual convertible preferreds were lower at about 46, which was down from 49.
A trader said trading in Energy XXI has been related to the company’s second-lien straight notes offering that priced last week.
Elsewhere, Akorn Inc.’s way-in-the-money 3.5% convertibles came down as shares of the Buffalo Grove, Ill.-based pharmaceutical company dropped sharply following news that Actavis plc is launching a skin cream that will compete with Akorn’s clobetasol cream, a major contributor to Akorn revenue.
Following the Actavis skin-cream news, Akorn reaffirmed full-year guidance, but Jefferies cut its share price target on Akorn to $56.00 from $59.00, and Sterne Agee cut its forecast to $51.00, citing concerns about the potential impact of the rival product.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.